Cycle Pharmaceuticals logo

Cycle Pharmaceuticals

Brand · Pharmaceutical Manufacturing

3.1

Company overview

We’re committed to supporting patients and their caregivers in every way we can. They are at the heart of everything we do. We focus on providing treatments and services for patients with neurological, rare metabolic, and rare immunological conditions, most of which are genetic conditions. We also provide a treatment for patients with rare types of leukaemia. We’re headquartered in Cambridge, UK and have staff working across the US, with an office in Detroit, MI.
Founded in 2012
Cambridge, England, GBR
227 employees (17 in marketing)
61% recommend to a friend
58% positive business outlook

Salaries

Help build salary transparency at Cycle Pharmaceuticals

Share your compensation anonymously to see full data.

Contribute

People

Headcount trend

Company growth over the last 12 months

Headcount +58.3% year over year

Funding

Total funding

$25M

Last raise

$25M

Debt Financing, 6 years ago

Funding history

Sep 2020

Debt Financing Cycle Pharmaceuticals · $25M

Audience

Monthly website visitors
5.8K
Month over month+18.2%
Quarter over quarter-7.2%
Top sourceDirect (43%)
Ad budget per month$0.0
Average search rank36
Traffic source mix
Direct
43%
Search
39.9%
Social
9.9%
Referral
5.9%
Paid referral
1.2%

LinkedIn followers

Follower count and growth

Total followers

18.9K

12-mo growth

+57.1%

Monthly growth

+5.3%

News

Links